Immunic Inc (NASDAQ: IMUX) kicked off on Tuesday, down -6.46% from the previous trading day, before settling in for the closing price of $0.82. Over the past 52 weeks, IMUX has traded in a range of $0.56-$2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 28.99%. With a float of $92.56 million, this company’s outstanding shares have now reached $95.82 million.
In an organization with 91 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immunic Inc is 3.40%, while institutional ownership is 40.58%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.99% per share during the next fiscal year.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Take a look at Immunic Inc’s (IMUX) current performance indicators. Last quarter, stock had a quick ratio of 0.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.98, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.02 million. That was inferior than the volume of 1.18 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.08%. Additionally, its Average True Range was 0.08.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 25.00%, which indicates a significant decrease from 58.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 140.98% in the past 14 days, which was higher than the 94.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9398, while its 200-day Moving Average is $1.1534. However, in the short run, Immunic Inc’s stock first resistance to watch stands at $0.8217. Second resistance stands at $0.8758. The third major resistance level sits at $0.9117. If the price goes on to break the first support level at $0.7317, it is likely to go to the next support level at $0.6958. Assuming the price breaks the second support level, the third support level stands at $0.6417.
Immunic Inc (NASDAQ: IMUX) Key Stats
The company with the Market Capitalisation of 73.54 million has total of 95,818K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -100,510 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -25,470 K.
